IL-4 and IL-10 halt pro-inflammatory cytokine release from monocytes and synovial fibroblasts, and their levels were reduced in RA patients, as also evident in DC animals in the current study (Mateen et al., 2016). The gene discussed is IL10; the disease is rheumatoid arthritis.